GlassScriptPhysician profile
Michael P Muldoon
NPI 1356428148
$48,922.06
in general payments reported to CMS, 2019-2025
23 companies · $2,549 in 2025
The $2,549 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $5,211 · 2021: $6,376 · 2022: $10K · 2023: $250 · 2024: $83.90 · 2025: $2,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,375 · Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,375.00 |
| Food and Beverage | $507.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $35,088.55 | 2019-2025 | Insignia |
| Encore Medical, LP | $9,947.68 | 2019-2023 | Djo Surgical |
| Smith+Nephew, INC. | $2,798.63 | 2019-2024 | Katalyst Bipolar Radial Head System |
| Acumed LLC | $144.36 | 2023 | Acumed |
| Pacira Pharmaceuticals Incorporated | $140.42 | 2020-2025 | Exparel |
| Breg, INC | $127.79 | 2022 | |
| Nevro Corp. | $118.22 | 2022 | |
| Boston Scientific Corporation | $115.72 | 2022 | |
| Zimmer Biomet Holdings, INC. | $82.47 | 2020-2022 | |
| Omnilife Science, INC | $79.74 | 2023-2024 | Omnibotics 3.0, Various Products |
| Guard Medical INC. | $34.38 | 2025 | Npseal |
| Ermi LLC | $30.50 | 2021-2022 | |
| Integra Lifesciences Corporation | $24.05 | 2021 | |
| Karl Storz Endoscopy-America | $22.92 | 2021 | |
| Heron Therapeutics, INC. | $22.21 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $21.37 | 2022 | |
| Heraeus Medical, LLC. | $20.11 | 2021 | |
| Kci USA, INC. | $19.84 | 2022 | |
| Linvatec Corporation | $19.06 | 2021 | |
| Baudax Bio INC. | $18.08 | 2020 | |
| Ethicon US, LLC | $16.88 | 2020 | |
| Innovation Technologies INC | $15.01 | 2024 | Irrisept |
| Pfizer INC. | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Muldoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.